Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease.
Weiner, H L
Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease. [electronic resource] - Annals of neurology Oct 2000 - 567-79 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0364-5134
Administration, Intranasal
Alzheimer Disease--drug therapy
Amyloid--analysis
Amyloid beta-Peptides--administration & dosage
Analysis of Variance
Animals
Brain--drug effects
Brain Chemistry
Disease Models, Animal
Enzyme-Linked Immunosorbent Assay
Humans
Immunohistochemistry
Mice
Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease. [electronic resource] - Annals of neurology Oct 2000 - 567-79 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0364-5134
Administration, Intranasal
Alzheimer Disease--drug therapy
Amyloid--analysis
Amyloid beta-Peptides--administration & dosage
Analysis of Variance
Animals
Brain--drug effects
Brain Chemistry
Disease Models, Animal
Enzyme-Linked Immunosorbent Assay
Humans
Immunohistochemistry
Mice